1 false false false false false false false false false false true false false false false false false No description of principal activity 2023-09-08 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 15125054 2023-09-08 2024-09-30 15125054 2024-09-30 15125054 2023-09-07 15125054 bus:Director1 2023-09-08 2024-09-30 15125054 core:WithinOneYear 2024-09-30 15125054 core:AfterOneYear 2024-09-30 15125054 core:ShareCapital 2024-09-30 15125054 core:RetainedEarningsAccumulatedLosses 2024-09-30 15125054 bus:SmallEntities 2023-09-08 2024-09-30 15125054 bus:AuditExemptWithAccountantsReport 2023-09-08 2024-09-30 15125054 bus:SmallCompaniesRegimeForAccounts 2023-09-08 2024-09-30 15125054 bus:PrivateLimitedCompanyLtd 2023-09-08 2024-09-30 15125054 bus:AbridgedAccounts 2023-09-08 2024-09-30
COMPANY REGISTRATION NUMBER: 15125054
Generx Life Limited
Filleted Unaudited Abridged Financial Statements
30 September 2024
Generx Life Limited
Abridged Statement of Financial Position
30 September 2024
30 Sep 24
Note
£
Current assets
Debtors
13,887
Cash at bank and in hand
556
--------
14,443
Creditors: amounts falling due within one year
18,076
--------
Net current liabilities
3,633
-------
Total assets less current liabilities
( 3,633)
Creditors: amounts falling due after more than one year
131,290
---------
Net liabilities
( 134,923)
---------
Capital and reserves
Called up share capital
1
Profit and loss account
( 134,924)
---------
Shareholders deficit
( 134,923)
---------
These abridged financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the abridged statement of comprehensive income has not been delivered.
For the period ending 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its abridged financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of abridged financial statements .
All of the members have consented to the preparation of the abridged statement of comprehensive income and the abridged statement of financial position for the period ending 30 September 2024 in accordance with Section 444(2A) of the Companies Act 2006.
Generx Life Limited
Abridged Statement of Financial Position (continued)
30 September 2024
These abridged financial statements were approved by the board of directors and authorised for issue on 29 August 2025 , and are signed on behalf of the board by:
Mr MJ Price
Director
Company registration number: 15125054
Generx Life Limited
Notes to the Abridged Financial Statements
Period from 8 September 2023 to 30 September 2024
1. General information
The company is a private company limited by shares, registered in England. The address of the registered office is 5th Floor, 18 St. Swithin's Lane, London, EC4N 8AD, England.
2. Statement of compliance
These abridged financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The abridged financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The abridged financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
These accounts have been prepared on the going concern basis on the understanding that the shareholders will provide financial support, if required, to enable the company to continue trading for a period of at least 12 months from the date of approval of these financial statements.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 .
5. Related party transactions
The company is controlled by the directors who own 100% of the issued share capital. Amounts owed to related parties:
2024
£
Tenth Bridge Consulting Ltd 131,290
Tenth Bridge Consulting Ltd is related to the company by virtue of common key management personnel.